CBD Legal Status in Africa

CBD Legal Status in Africa


Despite having near-perfect climate conditions for growing Cannabis, Africa has stringent laws for its usage. However, the continent is still looking to Cannabis as a way to get rid of poverty. It has ideal weather for growing Cannabis, so the continent also expects huge foreign investment for this sector. 


RESTRICTIONS IN AFRICA 


Most African countries have banned any cannabis extracts that include CBD. Before 1925, the cultivation of Cannabis was legal in Africa. After 1938, CBD was banned under Geneva International Opium Convention. Most African nations permit the cultivation of Cannabis only for food products for extracting fiber and seeds, and a few countries have legalized CBD for medical purposes. CBD products cannot be advertised in Africa or shown as a cure or treatment for any disease.


THC LEVEL
Hemp or CBD containing 0.2% THC is legal in Africa. 


CBD IS BANNED IN THE FOLLOWING COUNTRIES - 
In most African countries, CBD is banned. Here's the list below: Algeria, Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Chad, Côte d'Ivoire, Egypt, Democratic Republic of Congo, Equatorial Guinea, Eritrea, Ethiopia, Gabon, The Gambia, Guinea, Guinea-Bissau, Kenya, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Niger, Namibia, Nigeria, Rwanda, Senegal, Sierra Leone, Somalia, Zambia, Uganda, Togo.

 
Availability in South Africa 
You can find a variety of CBD products available in the store in South Africa. CBD is sold in one-stop shops, vape stores, and organic health and food stores.


Recently, The South African government has rescheduled CBD and THC to open up the cannabinoid economy. SAHPRA has issued guidelines regarding the cultivation of Cannabis only for medical, scientific, and clinical research purposes.


Now even small businesses would have to follow the pharmaceutical and medical legislation and regulatory requirements. Cultivators of Cannabis can apply to SAHPRA for a license under the Medicines and Related Substances Act (Medicines Act), authorizing the cultivation, extraction, and testing of Cannabis and Cannabis resins and the manufacture, import, export, and distribution of CBD infused products.